학술논문
Four Weeks Treatment with Glecaprevir/Pibrentasvir + Ribavirin—A Randomized Controlled Clinical Trial
Document Type
Article
Author
Source
In: Viruses . (Viruses, March 2022, 14(3))
Subject
Language
English
ISSN
19994915